Safety and Effectiveness of the PXL-Platinum 330 System for CXL Using Riboflavin Solution

NCT04177082 PHASE1 COMPLETED

Safety and Effectiveness of the PXL-Platinum 330 System for Corneal Collagen Cross-linking in Eyes With Corneal Thinning Conditions

Details

Lead sponsor	Cornea Associates of Texas
Phase	PHASE1
Status	COMPLETED
Enrolment	200
Start date	Fri Jan 10 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Completion	Thu May 05 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

• Keratoconus
• Pellucid Marginal Corneal Degeneration
• Corneal Degeneration
• Corneal Ectasia

Interventions

• PXL-330 Platinum device for crosslinking with Peschke riboflavin solution

Countries

United States